IP Library Granted Patent US 7,553,872
Granted Patent B2
US 7,553,872 · App. 11/354,045 · Granted Jun 30, 2009

Compounds and compositions for delivering active agents

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,553,872
App. No.
11/354,045
Granted
Jun 30, 2009
Kind
B2
Abstract

Carrier compounds and compositions therewith which are useful in the delivery of active agents are provided. Methods of administration and preparation are provided as well.

Claims (32)

1. A composition comprising:

(A) at least one active agent selected from human growth hormone, interferon, heparin, low molecular weight heparin, parathyroid hormone, and combinations thereof; and

(B) the compound represented by the formula

or a salt thereof.

2. The composition of claim 1 wherein said active agent is human growth hormone.

3. The composition of claim 1 wherein said active agent is interferon.

4. The composition of claim 1 wherein said active agent is heparin.

5. The composition of claim 1 wherein said active agent is low molecular weight heparin.

6. The composition of claim 1 wherein said active agent is parathyroid hormone.

7. A dosage unit form comprising

(A) a composition as defined in claim 1 and

(B) (a) an excipient,

(b) a diluent,

(c) a disintegrant,

(d) a lubricant,

(e) a plasticizer,

(f) a colorant,

(g) a dosing vehicle, or

(h) any combination thereof.

8. The dosage unit form of claim 7 comprising a tablet, a capsule, or a liquid.

9. The dosage unit form of claim 7 wherein said dosing vehicle is selected from the group consisting of water, 1,2-propane diol, ethanol, or any combination thereof.

10. The dosage unit form of claim 7 wherein said active agent is human growth hormone.

11. The dosage unit form of claim 7 wherein said active agent is interferon.

12. The dosage unit form of claim 7 wherein said active agent is heparin.

13. The dosage unit form of claim 7 , wherein said active agent is low molecular weight heparin.

14. The dosage unit form of claim 7 wherein said active agent is parathyroid hormone.

15. A method for administering an active agent to an animal in need of said agent, said method comprising administering orally to said animal the composition of claim 1 .

16. The method of claim 15 wherein said active agent is human growth hormone.

17. The method of claim 15 wherein said active agent is interferon.

18. The method of claim 15 wherein said active agent is heparin.

19. The method of claim 15 wherein said active agent is low molecular weight heparin.

20. The method of claim 15 wherein said active agent is parathyroid hormone.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 22, 2021
From: EMISPHERE TECHNOLOGIES, INC.
To: NOVO NORDISK NORTH AMERICA OPERATIONS A/S
Reel/Frame 056750/0169 →
SECURITY AGREEMENT Recorded Aug 8, 2006
From: EMISPHERE TECHNOLOGIES, INC.
To: MHR INSTITUTIONAL PARTNERS IIA LP
Reel/Frame 018073/0035 →